NZ734644A - Chemically encoded spatially addressed library screening platforms - Google Patents

Chemically encoded spatially addressed library screening platforms

Info

Publication number
NZ734644A
NZ734644A NZ734644A NZ73464416A NZ734644A NZ 734644 A NZ734644 A NZ 734644A NZ 734644 A NZ734644 A NZ 734644A NZ 73464416 A NZ73464416 A NZ 73464416A NZ 734644 A NZ734644 A NZ 734644A
Authority
NZ
New Zealand
Prior art keywords
ligand domain
linker
library screening
spatially addressed
attached
Prior art date
Application number
NZ734644A
Other languages
English (en)
Inventor
Jacob Berlin
Gregory COPELAND
Kathleen Elison
Hurik Muradyan
Original Assignee
Hope City
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56789474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ734644(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hope City filed Critical Hope City
Priority to NZ772386A priority Critical patent/NZ772386B2/en
Publication of NZ734644A publication Critical patent/NZ734644A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
    • C40B50/16—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support involving encoding steps
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Structural Engineering (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ734644A 2015-02-24 2016-02-24 Chemically encoded spatially addressed library screening platforms NZ734644A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ772386A NZ772386B2 (en) 2016-02-24 Chemically encoded spatially addressed library screening platforms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562120262P 2015-02-24 2015-02-24
PCT/US2016/019426 WO2016138184A1 (en) 2015-02-24 2016-02-24 Chemically encoded spatially addressed library screening platforms

Publications (1)

Publication Number Publication Date
NZ734644A true NZ734644A (en) 2023-02-24

Family

ID=56789474

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ734644A NZ734644A (en) 2015-02-24 2016-02-24 Chemically encoded spatially addressed library screening platforms

Country Status (19)

Country Link
US (6) US10760181B2 (enExample)
EP (4) EP3262059B1 (enExample)
JP (2) JP6872501B2 (enExample)
AU (2) AU2016222755B2 (enExample)
CA (1) CA2976946C (enExample)
CY (1) CY1124954T1 (enExample)
DK (3) DK3262059T3 (enExample)
ES (3) ES2965764T3 (enExample)
FI (2) FI3650458T3 (enExample)
HR (3) HRP20220093T1 (enExample)
HU (3) HUE058813T2 (enExample)
LT (3) LT3650459T (enExample)
NZ (1) NZ734644A (enExample)
PL (3) PL3650458T3 (enExample)
PT (3) PT3650459T (enExample)
RS (3) RS64567B1 (enExample)
SI (3) SI3262059T1 (enExample)
SM (3) SMT202300430T1 (enExample)
WO (1) WO2016138184A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2622112B2 (ja) 1986-09-26 1997-06-18 キヤノン株式会社 画像処理システム
WO2009069203A1 (ja) * 2007-11-28 2009-06-04 Glory Ltd. チケット処理装置、チケット処理システム及びチケット処理方法
EP3262059B1 (en) 2015-02-24 2022-01-05 City of Hope Chemically encoded spatially addressed library screening platforms
WO2016165621A1 (zh) * 2015-04-14 2016-10-20 成都先导药物开发有限公司 一种固相合成dna编码化合物库的方法
EP3538653B1 (en) * 2016-11-08 2021-07-28 Nanna Therapeutics Limited Tagless encoded chemical library
US11084037B2 (en) 2017-09-25 2021-08-10 Plexium, Inc. Oligonucleotide encoded chemical libraries
SG11202003923PA (en) 2017-10-31 2020-05-28 Encodia Inc Methods and kits using nucleic acid encoding and/or label
WO2021072306A1 (en) 2019-10-10 2021-04-15 1859, Inc. Methods and systems for microfluidic screening
WO2022170034A1 (en) * 2021-02-05 2022-08-11 Affinergy, Llc Rapid assay for apol1 g0 protein
EP4394383A4 (en) * 2021-08-27 2025-12-17 Univ Kobe Nat Univ Corp Core-shell-template-molecule/participant for high-yield pore formation technology on a substrate

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672040A (en) * 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0773227A1 (en) * 1991-09-18 1997-05-14 Affymax Technologies N.V. Diverse collections of oligomers in use to prepare drugs, diagnostic reagents, pesticides or herbicides
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5565324A (en) 1992-10-01 1996-10-15 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
AU5827294A (en) 1992-12-11 1994-07-04 Chiron Corporation Synthesis of encoded polymers
AU686186B2 (en) * 1993-05-27 1998-02-05 Aventisub Ii Inc. Topologically segregated, encoded solid phase libraries
EP1156059B1 (en) * 1993-06-21 2007-08-08 Aventis Pharmaceuticals, Inc. Selectively cleavable linkers based on a methionine group and an ester group
US6087186A (en) * 1993-07-16 2000-07-11 Irori Methods and apparatus for synthesizing labeled combinatorial chemistry libraries
CN1134156A (zh) * 1993-11-02 1996-10-23 阿菲马克斯技术公司 合成和筛选多种分子
US6936477B2 (en) 1994-04-13 2005-08-30 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US7615368B1 (en) 1994-06-17 2009-11-10 The Board Of Trustees Of The Leland Stanford Junior University Microarrays of polypeptides
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5846839A (en) 1995-12-22 1998-12-08 Glaxo Group Limited Methods for hard-tagging an encoded synthetic library
ES2288760T3 (es) * 1996-04-25 2008-01-16 Bioarray Solutions Ltd. Ensamblaje electrocinetico controlado por luz de particulas proximas a superficies.
WO1998001533A1 (en) * 1996-07-08 1998-01-15 Burstein Laboratories, Inc. Cleavable signal element device and method
DE69706187T2 (de) 1996-11-06 2002-04-11 Sequenom, Inc. Zusammensetzungen und verfahren zur immobilisierung von nukleinsäure auf festträgern
DE69940430D1 (de) * 1998-06-24 2009-04-02 Illumina Inc Dekodierung von matrixartig-angeordneten Sensoren durch Mikropartikel
US6429027B1 (en) * 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US20020150909A1 (en) * 1999-02-09 2002-10-17 Stuelpnagel John R. Automated information processing in randomly ordered arrays
US7932213B2 (en) 1999-05-11 2011-04-26 President And Fellows Of Harvard College Small molecule printing
US6824987B1 (en) 1999-05-11 2004-11-30 President And Fellows Of Harvard College Small molecule printing
US6544732B1 (en) * 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
US7160735B2 (en) 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
JP3899831B2 (ja) * 2001-03-02 2007-03-28 株式会社日立製作所 生化学センサ及びこれを用いた生化学検査装置
US20060040286A1 (en) 2001-03-28 2006-02-23 Nanosphere, Inc. Bio-barcode based detection of target analytes
US20030027221A1 (en) * 2001-04-06 2003-02-06 Scott Melissa E. High-throughput screening assays by encapsulation
US20030228619A1 (en) 2002-06-10 2003-12-11 Xenoport, Inc. Peptide nucleic acids as tags in encoded libraries
EP1774033A4 (en) * 2004-06-10 2008-04-23 Perkinelmer Las Inc MULTIPLEX ASSAYS FOR DETECTION OF ANALYTES
US20060134697A1 (en) * 2004-10-28 2006-06-22 The Regents Of The University Of California Method of preparing coded compound libraries
CA2622719A1 (en) * 2005-09-16 2007-07-26 The Regents Of The University Of California A colorimetric bio-barcode amplification assay for analyte detection
WO2010093705A2 (en) * 2009-02-10 2010-08-19 Idera Pharmaceuticals, Inc. Synthetic rna-based agonists of tlr7
US9172561B2 (en) 2009-07-29 2015-10-27 Qualcomm Incorporated Adaptive transmissions in coordinated multiple point communications
US20120129248A1 (en) * 2009-07-31 2012-05-24 Prognosys Biosciences, Inc. Assay tools and methods of use
WO2011143583A1 (en) * 2010-05-13 2011-11-17 Illumina, Inc. Binding assays for markers
CA2881602A1 (en) * 2012-08-14 2014-02-20 Angiochem Inc. Peptide-dendrimer conjugates and uses thereof
CA2880765C (en) * 2012-08-23 2023-01-10 Stemcell Technologies Inc. Compositions and methods for rapid and reversible biomolecular labeling
EP3262059B1 (en) * 2015-02-24 2022-01-05 City of Hope Chemically encoded spatially addressed library screening platforms

Also Published As

Publication number Publication date
HRP20230928T1 (hr) 2023-11-24
ES2904997T3 (es) 2022-04-06
CA2976946C (en) 2023-09-19
DK3650459T3 (da) 2023-12-11
RS64567B1 (sr) 2023-10-31
US20190390367A1 (en) 2019-12-26
EP3650458B1 (en) 2023-08-09
US20180245241A1 (en) 2018-08-30
JP7109618B6 (ja) 2022-08-22
US20200378032A1 (en) 2020-12-03
PT3262059T (pt) 2022-01-27
SI3262059T1 (sl) 2022-04-29
SI3650458T1 (sl) 2023-11-30
AU2016222755B2 (en) 2021-02-18
RS64899B1 (sr) 2023-12-29
HRP20220093T1 (hr) 2022-04-15
EP3650458A1 (en) 2020-05-13
CY1124954T1 (el) 2023-01-05
WO2016138184A1 (en) 2016-09-01
DK3262059T3 (da) 2022-01-31
JP6872501B2 (ja) 2021-05-19
AU2021200399B2 (en) 2023-04-20
EP4276059A2 (en) 2023-11-15
LT3650458T (lt) 2023-10-10
EP4276059A3 (en) 2024-05-01
US11015266B2 (en) 2021-05-25
EP3262059B1 (en) 2022-01-05
US20210324538A1 (en) 2021-10-21
US20200378031A1 (en) 2020-12-03
FI3650459T3 (fi) 2023-11-28
RS62847B1 (sr) 2022-02-28
DK3650458T3 (da) 2023-09-04
HUE064689T2 (hu) 2024-04-28
SMT202200039T1 (it) 2022-03-21
JP2018505700A (ja) 2018-03-01
EP3262059A4 (en) 2018-12-05
EP3262059A1 (en) 2018-01-03
PL3262059T3 (pl) 2022-02-21
PT3650459T (pt) 2023-12-06
US11015265B2 (en) 2021-05-25
FI3650458T3 (fi) 2023-08-21
HRP20231536T1 (hr) 2024-03-15
NZ772386A (en) 2024-10-25
US10767278B2 (en) 2020-09-08
US20220341059A1 (en) 2022-10-27
US10760181B2 (en) 2020-09-01
HUE063406T2 (hu) 2024-01-28
JP2021106607A (ja) 2021-07-29
EP3650459A1 (en) 2020-05-13
AU2016222755A1 (en) 2017-08-31
ES2965764T3 (es) 2024-04-16
AU2021200399A1 (en) 2021-03-18
LT3650459T (lt) 2023-12-27
CA2976946A1 (en) 2016-09-01
JP7109618B2 (ja) 2022-07-29
SMT202300430T1 (it) 2024-01-10
HUE058813T2 (hu) 2022-09-28
ES2954467T3 (es) 2023-11-22
DK3650458T5 (da) 2024-08-26
PL3650459T3 (pl) 2024-02-26
SMT202300275T1 (it) 2023-11-13
DK3650459T5 (da) 2024-08-26
PL3650458T3 (pl) 2023-11-06
PT3650458T (pt) 2023-08-31
EP3650459B1 (en) 2023-09-06
SI3650459T1 (sl) 2024-04-30
LT3262059T (lt) 2022-02-25

Similar Documents

Publication Publication Date Title
NZ734644A (en) Chemically encoded spatially addressed library screening platforms
BR112016006285A2 (pt) método implementado usando um sistema de computador, produto de programa de computador, e, sistema
EP3314578A4 (en) TECHNOLOGIES FOR THE PRODUCTION OF COMPUTER MODELS, DEVICES, SYSTEMS AND METHOD FOR USE THEREOF
EP3430137A4 (en) OLIGONUCLEOTIDE THONES AND USES THEREOF
WO2016040524A8 (en) Methods and compositions for rapid nucleic acid library preparation
GB201914881D0 (en) De novo synthesized combinatorial nucleic acid libraries
EP3632151A4 (en) DEVICES, PROCESSES AND SYSTEMS WITH DYNAMIC SPECTRUM DIVISION
EP3427295A4 (en) CONDUCTIVE STRUCTURES, SYSTEMS AND DEVICES WITH CONDUCTIVE STRUCTURES AND RELATED METHODS
MX387517B (es) Polipeptidos que contienen dominios de union de novo y usos de los mismos.
EP3464597A4 (en) OLIGONUCLEOTID PROBE AND USES THEREOF
BR112016017155A2 (pt) Sistema e dispositivo para geração com alto rendimento de gotículas combinatoriais e métodos de uso
WO2015153501A3 (en) Modified santalene synthase polypeptides, encoding nucleic acid molecules and uses thereof
DK3067817T3 (da) Dynamisk data-maskering til mainframe-applikation
EP3475419A4 (en) ENZYME WITH FRUCTANHYDROLASE ACTIVITY
CL2018001275A1 (es) Sistema de detección electroquímica de moléculas de interés
EP3734602A4 (en) SYSTEM FOR BUILDING A WHOLE GENOME SGRNA LIBRARY AND APPLICATION OF IT
EP3334870A4 (en) CONNECTOR SYSTEMS, ARRANGEMENTS AND METHOD
DK3271968T3 (da) Amplitudesammenlignings-monoimpulsradarsystem
BR112018075816A2 (pt) métodos para glicosilação de um substrato e para produção de glicose-1-fosfato.
LT3481804T (lt) Radioaktyviai pažymėto prostatos specifinio membranos antigeno (psma) inhibitoriaus [18f]dcfpyl pagerinta sintezė
EP3673076A4 (en) Bret sensor molecules for detecting hydrolases
BR112018075360A2 (pt) método, sistema e meio legível por máquina tangível
WO2015029037A3 (en) Method and system handling malware
CL2017002701A1 (es) Composiciones y métodos para la vigilancia activa del cáncer de próstata.
MX2015012093A (es) Sistemas de pintura que contienen celulosa.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 FEB 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20240111

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 FEB 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20250109